Global Cancer Pain Epidemiology and Patient Flow Analysis 2018 - Focus on US, Germany, France, Spain, Italy, UK, and Japan

DUBLIN, April 19, 2018 /PRNewswire/ --

The "Global Cancer Pain Epidemiology and Patient Flow Analysis - 2018" report has been added to ResearchAndMarkets.com's offering.

The research provides insights into Cancer Pain epidemiology, Cancer Pain diagnosed patients, and Cancer Pain treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of Cancer Pain derived from epidemiological analysis, patients diagnosed with Cancer Pain, and patients treated with a drug therapy.

The research study helps executives estimate Cancer Pain market potential, assess unmet need, develop drug forecasting models, and build population-based health management frameworks. The information presented in this study is used to evaluate market opportunities, effectively identify target patient population, and align marketing decisions.

The research provides estimates and forecasts of Cancer Pain prevalence, Cancer Pain diagnosis rate, and Cancer Pain treatment rate for the period 2017 - 2026. The information is presented by leading geographies including the US, Germany, France, Spain, Italy, UK, and Japan.

Key Topics Covered:

1. Cancer Pain: Disease Definition

2. Global Cancer Pain Patient Flow

2A. Global Cancer Pain Prevalence

2B. Global Cancer Pain Diagnosed Patients

2C. Global Cancer Pain Treated Patients

3. Cancer Pain Patient Flow in the US

3A. Cancer Pain Prevalence in the US

3B. Cancer Pain Diagnosed Patients in the US

3C. Cancer Pain Treated Patients in the US

4. Cancer Pain Patient Flow in Europe

4A. Cancer Pain Prevalence in Europe

4B. Cancer Pain Diagnosed Patients in Europe

4C. Cancer Pain Treated Patients in Europe

5. Cancer Pain Patient Flow in Germany

5A. Cancer Pain Prevalence in Germany

5B. Cancer Pain Diagnosed Patients in Germany

5C. Cancer Pain Treated Patients in Germany

6. Cancer Pain Patient Flow in France

6A. Cancer Pain Prevalence in France

6B. Cancer Pain Diagnosed Patients in France

6C. Cancer Pain Treated Patients in France

7. Cancer Pain Patient Flow in Spain

7A. Cancer Pain Prevalence in Spain

7B. Cancer Pain Diagnosed Patients in Spain

7C. Cancer Pain Treated Patients in Spain

8. Cancer Pain Patient Flow in Italy

8A. Cancer Pain Prevalence in Italy

8B. Cancer Pain Diagnosed Patients in Italy

8C. Cancer Pain Treated Patients in Italy

9. Cancer Pain Patient Flow in UK

9A. Cancer Pain Prevalence in UK

9B. Cancer Pain Diagnosed Patients in UK

9C. Cancer Pain Treated Patients in UK

10. Cancer Pain Patient Flow in Japan

10A. Cancer Pain Prevalence in Japan

10B. Cancer Pain Diagnosed Patients in Japan

10C. Cancer Pain Treated Patients in Japan

For more information about this report visit

https://www.researchandmarkets.com/research/t4l22t/global_cancer?w=5

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets